Medical Services International Gets Ready for the West Nile Virus
EDMONTON, Alberta -- Medical Services International Inc. announces that all of the appropriate testing for its VScan West Nile test kit will be completed by the
end of May 2004. The company has purchased all the necessary equipment to
allow it to begin large scale production of the West Nile rapid test kit
immediately.
The company developed this test kit as a result of a license agreement
with the Public Health Service in the United States. The West Nile test kit
detects the West Nile virus in humans. The company has also developed a test
kit that is able to detect the West Nile virus in animals.
The VScan rapid test kit is a single-use, easy-to-use test for the screening of HIV 1 and 2 and subgroup O, hepatitis B and C, Tuberculosis (TB) and West Nile. The kits cannot be sold in Canada.
Source: Medical Services International Inc.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
